 |
Novartis International AG (VTX:NOVN) Novartis Launches Extavia®, A New Therapeutic Option To Help Patients Combat Devastating Symptoms Of Multiple Sclerosis
JAN 22, 2009 17:17 - Article Views: 1,349
Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
|
 |
|
Novartis International AG (VTX:NOVN) Four Innovative Novartis Medicines For Cancer, Asthma, High Blood Pressure And Wet AMD Approved In Japan
JAN 21, 2009 17:17 - Article Views: 833
Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
|
|
|
Novartis International AG (VTX:NOVN) US Department Of Health And Human Services Awards Novartis USD 486 million Contract To Build Manufacturing Facility For Pandemic Flu Vaccine
JAN 16, 2009 02:03 - Article Views: 1,075
Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
|
|
|
Novartis International AG (VTX:NOVN) New Study First To Confirm Sandostatin® LAR® Controls Tumor Growth In Patients With Rare Gastrointestinal Tumors
JAN 14, 2009 10:03 - Article Views: 1,591
Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
|
|
|
Novartis International AG (VTX:NOVN) Afinitor® Phase II Trial Results Positive In Patients With Advanced Gastric Cancer After Failure Of One Or More Prior Treatments
JAN 14, 2009 10:01 - Article Views: 695
Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
|
|
|
Novartis International AG (VTX:NOVN) Novartis Strengthens Vaccine Pipeline With Agreement For Novel CMV vaccines Candidate
DEC 29, 2008 17:17 - Article Views: 577
Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
|
|
|
Novartis International AG (VTX:NOVN) Glivec Receives US Approval As First Treatment To Reduce Risk Of Cancer Returning In Patients With Gastrointestinal Stromal Tumors
DEC 20, 2008 12:17 - Article Views: 6,446
Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
|
|
|
Novartis International AG (VTX:NOVN) Afinitor® Shows Potential To Reverse Resistance To Herceptin®[*] In Metastatic Breast Cancer Patients, Leading To Phase III Trial
DEC 13, 2008 10:03 - Article Views: 677
Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
|
|
|
Novartis International AG (VTX:NOVN) First Phase III Results For FTY720, A Novel Oral Therapy For MS, Show Superior Efficacy Compared To Interferon Beta-1a
DEC 12, 2008 17:17 - Article Views: 803
Novartis International AG (VTX:NOVN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
|
|
